The 80th Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 1-14A ALL: Basic (1)

Fri. Oct 12, 2018 9:00 AM - 10:00 AM No.14 (Osaka International Convention Center, 8F 801-2)

Chair: Takeshi Inukai (Pediatrics, University of Yamanashi, Japan)

Yoichi Tanaka1, Kevin Urayama2, Makiko Mori3, Daisuke Hasegawa4, Koshi Akahane5, Setsuo Ota6, Katsuyoshi Koh3, Atsushi Manabe4 (1.Clinical Pharmacy, School of Pharmacy, Kitasato University, Tokyo, Japan, 2.National Center for Child Health and Development, Tokyo, Japan, 3.Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan, 4.Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan, 5.Department of Pediatrics, University of Yamanashi, Yamanashi, Japan, 6.Department of Pediatrics, Teikyo University Chiba Medical Center, Chiba, Japan)

Atsushi Watanabe1, Miyake Kunio2, van der Weyden Louise3, Norimasa Yamasaki4, Hiroaki Honda4, Akiko Nagamachi4, Toshiya Inaba4, Tamao Shinohara1, Keiko Kagami1, Masako Abe1, Koshi Akahane1, Kumiko Goi1, Kanji Sugita1, Takeshi Inukai1 (1.Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Japan, 2.Department of Epigenetic Medicine, Faculty of Medicine, University of Yamanashi,Japan, 3.Experimental Cancer Genetics, Wellcome Trust Genome Campus, UK, 4.Research Institute of Radiation Biology and Medicine, Hiroshima University, Japan)

Takuyo Kanayama1, Toshihiko Imamura1, Kenichi Sakamoto1, Fumihiko Hayakawa2, Akihiko Tanizawa3, Nobutaka Kiyokawa4, Hajime Hosoi1 (1.Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2.Department of Hematology and Oncology, Nagoya University, Nagoya, Japan, 3.Department of Pediatrics, University of Fukui, Fukui, Japan, 4.National Center for Child Health and Development, Tokyo, Japan)

Hisayuki Yao1, Trevor Price2, Matthew Warner2,3, Gaia Cantelli2, Brandon Ngo2, Lindsey Olivere2, Sarah Ridge2, Joe Therrien4, Stacey Tannheimer4, Chad Mccall2, Anjen Chenn5, Dorothy Sipkins2 (1.Hiroshima-Nishi Medical Center, Hiroshima, Japan, 2.Duke University, Durham, U.S.A., 3.Vitrisa Therapeutics, Inc., Durham, U.S.A., 4.Gilead Sciences, Inc., Foster, U.S.A., 5.LabCorp, Research Triangle Park, U.S.A.)